title: Should we continue to monitor 4CMenB coverage with MATS?
authors.affiliation: Instituto de Salud Carlos III, Majadahonda 28220, Spain.
authors.forename: Raquel
authors.initials: R
authors.lastname: Abad
authors.affiliation: Instituto de Salud Carlos III, Majadahonda 28220, Spain. Electronic address: jvazquez@isciii.es.
authors.forename: Julio
authors.initials: J
authors.lastname: Vazquez
mesh_terms: D006801:Humans; D000498:Allyl Compounds; D008589:Meningococcal Infections; D022401:Meningococcal Vaccines; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology; D013440:Sulfides
chemical_list: D000498:Allyl Compounds; D022401:Meningococcal Vaccines; D013440:Sulfides